Literature DB >> 35654996

Patient-reported outcome and cognitive measures to be used in vascular and brain tumor surgery: proposal for a minimum set.

Silvia Schiavolin1, Arianna Mariniello2, Morgan Broggi3, Giorgia Abete-Fornara4, Alessandra Bollani5,6, Giulio Palmas G5,6, Gabriella Bottini5,6,7, Matteo Querzola6, Pina Scarpa6, Alessandra Casarotti8, Sara De Michele9, Valeria Isella10, Ilaria Mauri10, Alessandra Maietti11, Valentina Miramonti12, Maria Immacolata Orru13, Marta Pertichetti14, Elisa Pini15, Rossana Regazzoni16, Sara Subacchi17, Paolo Ferroli3, Matilde Leonardi1.   

Abstract

BACKGROUND: The standardization of outcome measures is needed for comparing studies and using common measures in clinical practice. We aimed to identify cognitive and patient-reported outcomes and timing of assessment for glioma, meningioma, and vascular surgery.
METHOD: A consensus study was conducted. Participants selected cognitive and patient-reported measures among a list of instruments identified through a literature search.
RESULTS: Seventeen cognitive tests for the glioma and meningioma's evaluation, 8 for the vascular diseases, and one questionnaire on quality of life and one on emotional distress were identified. The timing of outcome assessment selected was before surgery, at discharge, and after 3 and 12 months for glioma; before surgery and after 3 months for meningioma; before surgery, at discharge, and after 6 months for vascular diseases.
CONCLUSION: The identification of common outcome measures is the first step toward a shared data collection improving the quality and comparability of future studies.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Cognitive test; Consensus; Glioma; Meningioma; Patient-reported outcome measure (PROM); Vascular

Mesh:

Year:  2022        PMID: 35654996     DOI: 10.1007/s10072-022-06162-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  23 in total

1.  Measuring clinical outcomes in neuro-oncology. A battery to evaluate low-grade gliomas (LGG).

Authors:  Costanza Papagno; Alessandra Casarotti; Alessandro Comi; Marcello Gallucci; Marco Riva; Lorenzo Bello
Journal:  J Neurooncol       Date:  2012-02-24       Impact factor: 4.130

2.  National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods.

Authors:  Stacie T Grinnon; Kristy Miller; John R Marler; Yun Lu; Alexandra Stout; Joanne Odenkirchen; Selma Kunitz
Journal:  Clin Trials       Date:  2012-02-27       Impact factor: 2.486

Review 3.  Cognitive Impairment After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Authors:  Syed Faraz Kazim; Jonathan V Ogulnick; Myranda B Robinson; Javed Khader Eliyas; Benjamin Q Spangler; Tyler J Hough; Erick Martinez; Zafar Karimov; Devan W Vidrine; Meic H Schmidt; Christian A Bowers
Journal:  World Neurosurg       Date:  2021-01-20       Impact factor: 2.104

Review 4.  Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.

Authors:  Terri S Armstrong; Linda Dirven; David Arons; Amanda Bates; Susan M Chang; Corneel Coens; Claire Espinasse; Mark R Gilbert; David Jenkinson; Paul Kluetz; Tito Mendoza; Larry Rubinstein; Joohee Sul; Michael Weller; Patrick Y Wen; Martin J van den Bent; Martin J B Taphoorn
Journal:  Lancet Oncol       Date:  2020-02       Impact factor: 41.316

5.  Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.

Authors:  Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

6.  Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas.

Authors:  Martin L Waagemans; David van Nieuwenhuizen; Monica Dijkstra; Miriam Wumkes; Clemens M F Dirven; Sieger Leenstra; Jaap C Reijneveld; Martin Klein; Lukas J A Stalpers
Journal:  Neurosurgery       Date:  2011-07       Impact factor: 4.654

7.  Late neurocognitive sequelae in patients with WHO grade I meningioma.

Authors:  M Dijkstra; D van Nieuwenhuizen; L J A Stalpers; M Wumkes; M Waagemans; W P Vandertop; J J Heimans; S Leenstra; C M Dirven; J C Reijneveld; M Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-07-24       Impact factor: 10.154

8.  Cognitive function of patients with brain tumor in pre- and postoperative stage.

Authors:  Yoshihiko Yoshii; Daisuke Tominaga; Kouichi Sugimoto; Yukihiro Tsuchida; Akio Hyodo; Hirokatsu Yonaha; Sukemitsu Kushi
Journal:  Surg Neurol       Date:  2008-01

9.  Developing core outcome sets for clinical trials: issues to consider.

Authors:  Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell
Journal:  Trials       Date:  2012-08-06       Impact factor: 2.279

Review 10.  Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs).

Authors:  Rhiannon C Macefield; Marc Jacobs; Ida J Korfage; Joanna Nicklin; Robert N Whistance; Sara T Brookes; Mirjam A G Sprangers; Jane M Blazeby
Journal:  Trials       Date:  2014-02-05       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.